Director/PDMR Transaction
Albion Technology & General VCT PLC
Director/PDMR Transaction
LEI Code 213800TKJUY376H3KN16
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
| a) | Name | Clive Richardson - Director of Albion Technology & General VCT PLC | |||
| 2 | Reason for notification | ||||
| a) | Position/status | PDMR/Director | |||
| b) | Initial notification/Amendment | Initial notification | |||
| 3) | Details of the issuer, emission allowance market participation, auction platform, | ||||
| auctioneer or auction monitor | |||||
| a) | Name | Albion Technology & General VCT PLC | |||
| b) | LEI | 213800TKJUY376H3KN16 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; | ||||
| (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument | ordinary shares of nominal value 1 penny each | |||
| Identification code | GB0005581672 | ||||
| b) | Nature of the transaction | Issue of shares under the Dividend Reinvestment Scheme | |||
| c) | Price(s) and volume(s) | Price | Volume | Amount | |
| £0.6649 | 328 | £218.09 | |||
| d) | Aggregated information | ||||
| - Aggregated volume | £218.09 | ||||
| e) | Date of the transaction | 30 October 2026 | |||
| f) | Place of the transaction | London Stock Exchange | |||
30 October 2026
For further information please contact:
Vikash Hansrani
Operations Partner
AlbionVC LLP
Tel: 020 7601 1850
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); and Planet Fitness, Inc. (NYSE: PLNT): Grabar Law Offic
- Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum
- Coastline Sunrooms Prices Four-Season Rooms at Three-Season Rates This Fall
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share